Striatal neuroprotection with methylene blue (2009)

Peer-Reviewed Study · Rojas JC, Simola N, Kermath BA, Kane JR, Schallert T, Gonzalez-Lima F · July 24, 2009

Rojas JC et al., 2009-07-24: Rat study showing that locally co-administered methylene blue reduced rotenone-induced striatal lesion size, preserved cytochrome oxidase activity, maintained motor-circuit functional connectivity and partly prevented sensorimotor asymmetry.

MB also prevented the indirect effects of the Rot-induced lesion on cytochrome oxidase activity in related motor regions

abstract

Rojas JC et al., 2009-07-24: Rat study showing that locally co-administered methylene blue reduced rotenone-induced striatal lesion size, preserved cytochrome oxidase activity, maintained motor-circuit functional connectivity and partly prevented sensorimotor asymmetry. Study type: animal (rat) neurotoxin model with stereology, cytochrome oxidase mapping and behavioural testing. N not stated in abstract. Country: USA. Dose/route: methylene blue co-administered locally with intrastriatal rotenone (dose not stated in abstract). Comparator: rotenone alone. Funder/conflicts: not stated in abstract. Model described by authors as 'metabolic strokes'. Study type: animal.